Average Co-Inventor Count = 4.29
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Roche Diagnostics Gmbh (10 from 480 patents)
2. Hoffmann-la Roche Inc. (8 from 4,945 patents)
3. Boehringer Mannheim Gmbh (8 from 1,164 patents)
4. F. Hoffmann-la Roche Ag (168 patents)
26 patents:
1. 9428766 - Protein expression from multiple nucleic acids
2. 8771988 - Protein expression from multiple nucleic acids
3. RE44389 - Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies
4. RE44359 - Nucleic acid molecules encoding anti-P-selectin antibodies
5. RE43568 - Anti-P-selectin antibodies
6. 7824684 - Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies
7. 7754867 - Nucleic acid molecules encoding anti-P-selectin antibodies
8. 7563441 - Anti-P-selectin antibodies
9. 7214532 - Methods for identifying human cell lines useful for endogenous gene activation, isolated human cell lines identified thereby, and uses thereof
10. 7186529 - Preparation of erythropoietin by endogenous gene activation
11. 7008764 - Optimization of cells for endogenous gene activation
12. 6555373 - Methods for identifying human cell lines useful for endogenous gene activation isolated human cell lines identified thereby, and uses thereof
13. 6548296 - Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof
14. 6544748 - Preparation of erythropoietin by endogenous gene activation
15. 6444441 - Production of human mutated proteins in human cells by means of homologous recombination